Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet - PubMed (original) (raw)
. 2013 Jul 14;110(1):77-85.
doi: 10.1017/S0007114512004801. Epub 2012 Dec 5.
Affiliations
- PMID: 23211714
- DOI: 10.1017/S0007114512004801
Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet
Anna Oksaharju et al. Br J Nutr. 2013.
Abstract
A high-fat diet disturbs the composition and function of the gut microbiota and generates local gut-associated and also systemic responses. Intestinal mast cells, for their part, secrete mediators which play a role in the orchestration of physiological and immunological functions of the intestine. Probiotic bacteria, again, help to maintain the homeostasis of the gut microbiota by protecting the gut epithelium and regulating the local immune system. In the present study, we explored the effects of two probiotic bacteria, Lactobacillus rhamnosus GG (GG) and Propionibacterium freudenreichii spp. shermanii JS (PJS), on high fat-fed ApoE*3Leiden mice by estimating the mast cell numbers and the immunoreactivity of TNF-α and IL-10 in the intestine, as well as plasma levels of several markers of inflammation and parameters of lipid metabolism. We found that mice that received GG and PJS exhibited significantly lower numbers of intestinal mast cells compared with control mice. PJS lowered intestinal immunoreactivity of TNF-α, while GG increased intestinal IL-10. PJS was also observed to lower the plasma levels of markers of inflammation including vascular cell adhesion molecule 1, and also the amount of gonadal adipose tissue. GG lowered alanine aminotransferase, a marker of hepatocellular activation. Collectively, these data demonstrate that probiotic GG and PJS tend to down-regulate both intestinal and systemic pro-inflammatory changes induced by a high-fat diet in this humanised mouse model.
Similar articles
- Development of new probiotics by strain combinations: is it possible to improve the adhesion to intestinal mucus?
Collado MC, Meriluoto J, Salminen S. Collado MC, et al. J Dairy Sci. 2007 Jun;90(6):2710-6. doi: 10.3168/jds.2006-456. J Dairy Sci. 2007. PMID: 17517710 - Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cells.
Oksaharju A, Kankainen M, Kekkonen RA, Lindstedt KA, Kovanen PT, Korpela R, Miettinen M. Oksaharju A, et al. World J Gastroenterol. 2011 Feb 14;17(6):750-9. doi: 10.3748/wjg.v17.i6.750. World J Gastroenterol. 2011. PMID: 21390145 Free PMC article. - Effects of multispecies probiotic combination on helicobacter pylori infection in vitro.
Myllyluoma E, Ahonen AM, Korpela R, Vapaatalo H, Kankuri E. Myllyluoma E, et al. Clin Vaccine Immunol. 2008 Sep;15(9):1472-82. doi: 10.1128/CVI.00080-08. Epub 2008 Jun 25. Clin Vaccine Immunol. 2008. PMID: 18579692 Free PMC article. - Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp shermanii JS administered in capsules is ineffective in lowering serum lipids.
Hatakka K, Mutanen M, Holma R, Saxelin M, Korpela R. Hatakka K, et al. J Am Coll Nutr. 2008 Aug;27(4):441-7. doi: 10.1080/07315724.2008.10719723. J Am Coll Nutr. 2008. PMID: 18978162 Clinical Trial. - Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus.
Collado MC, Jalonen L, Meriluoto J, Salminen S. Collado MC, et al. Asia Pac J Clin Nutr. 2006;15(4):570-5. Asia Pac J Clin Nutr. 2006. PMID: 17077078 Review.
Cited by
- Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer.
Lazar V, Ditu LM, Pircalabioru GG, Gheorghe I, Curutiu C, Holban AM, Picu A, Petcu L, Chifiriuc MC. Lazar V, et al. Front Immunol. 2018 Aug 15;9:1830. doi: 10.3389/fimmu.2018.01830. eCollection 2018. Front Immunol. 2018. PMID: 30158926 Free PMC article. Review. - Probiotic Propionibacterium freudenreichii requires SlpB protein to mitigate mucositis induced by chemotherapy.
do Carmo FLR, Rabah H, Cordeiro BF, da Silva SH, Pessoa RM, Fernandes SOA, Cardoso VN, Gagnaire V, Deplanche M, Savassi B, Figueiroa A, Oliveira ER, Fonseca CC, Queiroz MIA, Rodrigues NM, Sandes SHC, Nunes ÁC, Lemos L, Alves JL, Faria AMC, Ferreira Ê, Le Loir Y, Jan G, Azevedo V. do Carmo FLR, et al. Oncotarget. 2019 Dec 31;10(68):7198-7219. doi: 10.18632/oncotarget.27319. eCollection 2019 Dec 31. Oncotarget. 2019. PMID: 31921383 Free PMC article. - Probiotics as Complementary Treatment for Metabolic Disorders.
Le Barz M, Anhê FF, Varin TV, Desjardins Y, Levy E, Roy D, Urdaci MC, Marette A. Le Barz M, et al. Diabetes Metab J. 2015 Aug;39(4):291-303. doi: 10.4093/dmj.2015.39.4.291. Diabetes Metab J. 2015. PMID: 26301190 Free PMC article. Review. - Identification of Lactobacillus strains with probiotic features from the bottlenose dolphin (Tursiops truncatus).
Diaz MA, Bik EM, Carlin KP, Venn-Watson SK, Jensen ED, Jones SE, Gaston EP, Relman DA, Versalovic J. Diaz MA, et al. J Appl Microbiol. 2013 Oct;115(4):1037-51. doi: 10.1111/jam.12305. Epub 2013 Aug 1. J Appl Microbiol. 2013. PMID: 23855505 Free PMC article. - Anti-inflammatory and Antioxidant Properties of Probiotic Bacterium Lactobacillus mucosae AN1 and Lactobacillus fermentum SNR1 in Wistar Albino Rats.
Ayyanna R, Ankaiah D, Arul V. Ayyanna R, et al. Front Microbiol. 2018 Dec 14;9:3063. doi: 10.3389/fmicb.2018.03063. eCollection 2018. Front Microbiol. 2018. PMID: 30619149 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous